Literature DB >> 30854488

Liver transplantation for hepatocellular carcinoma: pushing the boundaries.

Joanne M O'Rourke1, Shishir Shetty1, Tahir Shah1, M Thamara P R Perera1.   

Abstract

Entities:  

Year:  2019        PMID： 30854488      PMCID： PMC6378266          DOI： 10.21037/tgh.2018.12.07

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  23 in total

Review 1.  Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.

Authors:  Vincenzo Mazzaferro; Sherrie Bhoori; Carlo Sposito; Marco Bongini; Martin Langer; Rosalba Miceli; Luigi Mariani
Journal:  Liver Transpl       Date:  2011-10       Impact factor: 5.799

2.  Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Authors:  F Y Yao; L Ferrell; N M Bass; J J Watson; P Bacchetti; A Venook; N L Ascher; J P Roberts
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

Review 3.  Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 4.  Is liver transplantation justified for the treatment of hepatic malignancies?

Authors:  K M Olthoff; J M Millis; M H Rosove; L I Goldstein; K P Ramming; R W Busuttil
Journal:  Arch Surg       Date:  1990-10

5.  The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.

Authors:  Shaheed Merani; Pietro Majno; Norman M Kneteman; Thierry Berney; Philippe Morel; Gilles Mentha; Christian Toso
Journal:  J Hepatol       Date:  2011-02-18       Impact factor: 25.083

6.  A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.

Authors:  Francis Y Yao; Ryutaro Hirose; Jeanne M LaBerge; Timothy J Davern; Nathan M Bass; Robert K Kerlan; Raphael Merriman; Sandy Feng; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2005-12       Impact factor: 5.799

7.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

8.  Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Authors:  John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

9.  Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients.

Authors:  B Ringe; R Pichlmayr; C Wittekind; G Tusch
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

10.  Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor.

Authors:  E Vibert; D Azoulay; E Hoti; S Iacopinelli; D Samuel; C Salloum; A Lemoine; H Bismuth; D Castaing; R Adam
Journal:  Am J Transplant       Date:  2010-01       Impact factor: 8.086
View more
  1 in total

1.  Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model.

Authors:  Zhi-Feng Zhou; Feng Peng; Jie-Yu Li; Yun-Bin Ye
Journal:  Onco Targets Ther       Date:  2019-09-20       Impact factor: 4.147
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.